RUNX1 Research Program is the world's only foundation supporting patients with RUNX1 Familial Platelet Disorder (RUNX1-FPD), a rare hereditary disease that affects blood platelets and can lead to other health concerns. Most notably, individuals with RUNX1-FPD have a 30 times higher risk of developing blood cancer compared to the general population. We fund innovative research focused on blood cancer prevention, and provide educational initiatives as well as opportunities for patients and their families to share their voices with researchers and clinicians.